The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis

Transdermal delivery of rotigotine maintains stable plasma concentrations for 24 hours. Three phase 3 studies of rotigotine as add-on to levodopa in advanced Parkinson's disease showed a significant reduction in “off” time from baseline to end of maintenance (EoM). However, detailed analyses ov...

Descripción completa

Detalles Bibliográficos
Autores principales: LeWitt, Peter A., Poewe, Werner, Elmer, Lawrence W., Asgharnejad, Mahnaz, Boroojerdi, Babak, Grieger, Frank, Bauer, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791317/
https://www.ncbi.nlm.nih.gov/pubmed/26882318
http://dx.doi.org/10.1097/WNF.0000000000000133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791317/
https://www.ncbi.nlm.nih.gov/pubmed/26882318
http://dx.doi.org/10.1097/WNF.0000000000000133

Ejemplares similares